Phase 3 Osteoarthritis Trial, Recruiting NCT07353931 Sponsor: Eli Lilly and Company Condition: Osteoarthritis
Back to Osteoarthritis

Phase 3 Osteoarthritis Trial, Recruiting

NCT07353931
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your Body Mass Index (BMI) is 27 or higher (a measure of weight relative to height) at the time of screening
  • Your weight has been fairly stable — changing less than 5% — for the past 3 months before screening
  • You have tried at least one diet to lose weight in the past but were not successful
  • You have osteoarthritis of the knee AND at least one of the following: you are over 50 years old, you experience morning knee stiffness lasting around 30 minutes, or you have a crackling or grinding sensation in your knee

Who may not be able to join:

  • You have had, or are planning to have, surgery specifically to treat obesity (note: certain cosmetic procedures like liposuction may be allowed if done more than 1 year before screening — confirm with trial site)
  • You have had, or are planning to have, a procedure or device-based treatment aimed at treating obesity (a past device may be acceptable if it was removed more than 6 months before screening — confirm with trial site)
  • You have any type of diabetes, including type 1 or type 2
  • You currently have an active infection in your knee
  • You have had a heart attack, stroke, a procedure to open blocked heart arteries, unstable chest pain, or been hospitalised for heart failure within the past 90 days
  • You have been diagnosed with the most severe category of heart failure (Class IV), which severely limits physical activity
  • You have taken any prescription or alternative medicines intended to help with weight loss within the past 90 days before screening

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company

Phone: 317-615-4559

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
9 February 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇦🇷 Argentina 🇧🇪 Belgium 🇧🇷 Brazil 🇨🇦 Canada 🇨🇳 China 🇨🇿 Czechia 🇩🇰 Denmark 🇩🇪 Germany 🇯🇵 Japan 🇲🇽 Mexico Puerto Rico 🇰🇷 South Korea 🇹🇼 Taiwan 🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

Percent Change from Baseline in Body Weight; Change from Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov